MedPath

Randomized trial on the effect of non-calcium-containing phosphate binder lanthanum carbonate on vascular calcification in hemodialysis patients

Phase 4
Conditions
end-stage renal disease
Registration Number
JPRN-UMIN000005483
Lead Sponsor
Department of Nephrology
Brief Summary

o result

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
300
Inclusion Criteria

Not provided

Exclusion Criteria

1) Contraindications to Ca carbonate and La carbonate 2) Severe GI disorders 3) History of obstructed bowels 4) History of IHD/stroke within 6 mo before randomization 5) Severe congestive heart failure 6) Severe liver dysfunction (AST or ALT greater than 3 times the upper limit of normal, hepatic cirrhosis) 7) Severe malnutrition 8) Malignancy of any type within the last five years 9) Severe infectious disease within 3 mo before randomization 10) Pregnant or possibly pregnant women and women on lactation 11) Ineligible patients according to the investigators judgment

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath